Amneal Celebrates FDA Approvals For Generic Namzaric And Afinitor Disperz

Also, Tentative Approval For Off-Patent Rival To Xifaxan Due To Ongoing Litigation

 
• By Urtė Fultinavičiūtė
  
Stamp saying approved
(Shutterstock)

More from Generics

More from Generics Bulletin